glp 1 agonists approved for weight loss The New Management Meds GLP-1: Genetic Variants Related to

And that could lead to new treatments for alcoholism and other substance use disorders

Effect of Metformin and exenatide on pregnancy rate and pregnancy outcomes in overweight or obese infertility PCOS women: Long-term follow-up of an RCT

45,160 In summary, most of the studied drugs did not show clinically significant DDIs related to delayed gastric emptying caused by GLP-1 RAs or a dual GLP-1/GIP RA administration

Front Endocrinol (Lausanne) 2021;12:649018

Glucagon-like peptide-1 receptor agonists as an effective therapeutic agent for diabetes mellitus and obesity in patients with schizophrenia under treatment with second-generation antipsychotics